Your browser doesn't support javascript.
loading
In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.
Kawai, Yasuhiro; Nakura, Yukiko; Wakimoto, Tetsu; Nomiyama, Makoto; Tokuda, Tsugumichi; Takayanagi, Toshimitsu; Shiraishi, Jun; Wasada, Kenshi; Kitajima, Hiroyuki; Fujita, Tomio; Nakayama, Masahiro; Mitsuda, Nobuaki; Nakanishi, Isao; Takeuchi, Makoto; Yanagihara, Itaru.
Afiliação
  • Kawai Y; Department of Developmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Nakura Y; Department of Developmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Wakimoto T; Department of Developmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.
  • Nomiyama M; Department of Obstetrics and Gynecology, Perinatal Center, National Hospital Organization Saga National Hospital, Saga City, Saga, Japan.
  • Tokuda T; Department of Obstetrics and Gynecology, Perinatal Center, National Hospital Organization Saga National Hospital, Saga City, Saga, Japan.
  • Takayanagi T; Department of Pediatrics, National Hospital Organization Saga National Hospital, Saga City, Saga, Japan.
  • Shiraishi J; Department of Neonatology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Wasada K; Department of Obstetrics and Gynecology, Aizenbashi Hospital, Osaka City, Osaka, Japan.
  • Kitajima H; Department of Neonatology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Fujita T; Fujita Clinic, Osaka City, Osaka, Japan.
  • Nakayama M; Department of Pathology and Laboratory Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Mitsuda N; Department of Obstetrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Nakanishi I; Department of Maternal Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Takeuchi M; Department of Pathology and Laboratory Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan.
  • Yanagihara I; Department of Developmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan itaruy@mch.pref.osaka.jp.
Antimicrob Agents Chemother ; 59(4): 2358-64, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25645833
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ureaplasma / Ureaplasma urealyticum / Infecções por Ureaplasma / Quinolonas / DNA Girase / DNA Topoisomerase IV / Farmacorresistência Bacteriana Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Pregnancy País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ureaplasma / Ureaplasma urealyticum / Infecções por Ureaplasma / Quinolonas / DNA Girase / DNA Topoisomerase IV / Farmacorresistência Bacteriana Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Pregnancy País como assunto: Asia Idioma: En Ano de publicação: 2015 Tipo de documento: Article